The rise of skincare culture has been a dominant thread on social media lately – particularly among Millennials and Gen Zs.
2025
Melanoma: Risk factors, diagnosis and treatment
Incidence and epidemiology of melanoma in Ireland
FDA Grants Priority Review to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy
The FDA has accepted and granted priority review to the biologics license application (BLA) seeking the approval of RP1 (vusolimogene oderparepvec) in combination with nivolumab (Opdivo) for the treatment of adult patients with advanced melanoma who have received prior treatment with a PD-1 inhibitor–containing regimen.
3D models of uveal melanoma offer hope for improved treatments
Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this disease works and develop treatments for unmet patient needs.